Aroa Biosurgery Limited

ASX:ARX.AX

0.56 (AUD) • At close November 5, 2024
Bedrijfsnaam Aroa Biosurgery Limited
Symbool ARX.AX
Munteenheid AUD
Prijs 0.56
Beurswaarde 193,144,000
Dividendpercentage 0%
52-weken bereik 0.44 - 0.87
Industrie Medical Devices
Sector Healthcare
CEO Dr. Brian Ward
Website https://aroabio.com

An error occurred while fetching data.

Over Aroa Biosurgery Limited

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad

Vergelijkbare Aandelen

Race Oncology Limited logo

Race Oncology Limited

RAC.AX

1.585 AUD

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.975 AUD

Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

PAR.AX

0.22 AUD

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.83 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.1 AUD

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPL.AX

0.1 AUD

Anteris Technologies Ltd logo

Anteris Technologies Ltd

AVR.AX

10.2 AUD

Immutep Limited logo

Immutep Limited

IMM.AX

0.28 AUD

PYC Therapeutics Limited logo

PYC Therapeutics Limited

PYC.AX

0.19 AUD

Capitol Health Limited logo

Capitol Health Limited

CAJ.AX

0.36 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)